Viewing a single comment thread. View all comments

Ezekiel_W OP t1_irxairn wrote

>In a paper recently published in Nature Nanotechnology, Siegwart and his team developed a dual approach using LNPs equipped with tools that allow them to access and modify the tumor.4 The researchers packaged the LNPs with a CRISPR-Cas9 system that genetically modified and disrupted PD-L1 gene expression. PD-L1 overexpression inhibits T cell infiltration within the tumor microenvironment, so deactivating the gene allows immune cells to access the tumor. To grant the CRISPR system and immune cells tumor access, the LNP also included siRNA that targeted and reduced the expression of focal adhesion kinase (FAK), which diminished the density of the extracellular matrix surrounding the tumor.

16

gibecrake t1_irxpkcv wrote

I'm actually surprised CRISPER hasn't made even more groundbreaking breakthroughs. I think we might see a different story once someone decides to pair it with some of the newer AI models. Watch me cry sarcastic tears as the pharma industry dries up.

21

Ezekiel_W OP t1_irxtiqr wrote

CRISPR is continually making breakthroughs, posting all of them would mean posting almost every day with updates, which I am too lazy for.

16

arevealingrainbow t1_iryh42x wrote

The #1 reason CRISPR isn’t as transformative of a technology as it should be is because the FDA is stuck in the 20th century.

12

-ZeroRelevance- t1_is0d8rb wrote

The mad scientist in me kind of wants them to completely get rid of the regulations and see how much faster we would be able to advance

9

rredirt t1_irzz9rg wrote

Who do you think is getting all the patents and is paying for all of these breakthroughs? Pharma will not own directly those patents but will always owns the mean to the product and compounds productions.

1